CADM1 and neoplasm: Searches for putative TSGs have identified only few candidates, with tumor-specific promoter methylation, such as BLU and RASSF1A at 3p21 [7], [8], CADM1/TSLC1 at 11q23.1 [9]; THY1/CD90 at 11q22.3 [10], CDH1 at 16q22.1 [11], RASAL1[12], ADAMTS18 and CDH13 at 16q23 [13], [14].